218 related articles for article (PubMed ID: 193451)
1. Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycemic disorders.
Rubenstein AH; Kuzuya H; Horwitz DL
Arch Intern Med; 1977 May; 137(5):625-32. PubMed ID: 193451
[TBL] [Abstract][Full Text] [Related]
2. C-peptide measurement: methods and clinical utility.
Bonser AM; Garcia-Webb P
Crit Rev Clin Lab Sci; 1984; 19(4):297-352. PubMed ID: 6373142
[TBL] [Abstract][Full Text] [Related]
3. Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies.
Scarlett JA; Mako ME; Rubenstein AH; Blix PM; Goldman J; Horwitz DL; Tager H; Jaspan JB; Stjernholm MR; Olefsky JM
N Engl J Med; 1977 Nov; 297(19):1029-32. PubMed ID: 198659
[TBL] [Abstract][Full Text] [Related]
4. Insulin biosynthesis and C-peptide. Practical applications from basic research.
Sperling MA
Am J Dis Child; 1980 Dec; 134(12):1119-21. PubMed ID: 7004174
[No Abstract] [Full Text] [Related]
5. Clinical significance of circulating proinsulin and C-peptide.
Rubenstein AH; Steiner DF; Horwitz DL; Mako ME; Block MB; Starr JI; Kuzuya H; Melani F
Recent Prog Horm Res; 1976; 33():435-75. PubMed ID: 198859
[No Abstract] [Full Text] [Related]
6. Circulating serum C-peptide. A brief review of diagnostic implications.
Horwitz DL; Kuzuya H; Rubenstein AH
N Engl J Med; 1976 Jul; 295(4):207-9. PubMed ID: 179006
[No Abstract] [Full Text] [Related]
7. C-peptide in conditions other than diabetes mellitus.
Horwitz DL; Rubenstein AH; Mako ME; Cruz A; Blix PM
Diabetes; 1978; 27 Suppl 1():267-71. PubMed ID: 631444
[TBL] [Abstract][Full Text] [Related]
8. [Pancreatic B cell peptides: kinetic behaviour and concentrations of proinsulin, insulin and C-peptide in plasma and urine, problems of assay methods, clinical significance and literature review (author's transl)].
Gerbitz KD
J Clin Chem Clin Biochem; 1980 Jun; 18(6):313-26. PubMed ID: 7000969
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis of islet cell adenoma].
Bottermann P
Med Klin; 1979 Dec; 74(51-52):1943-51. PubMed ID: 232238
[No Abstract] [Full Text] [Related]
10. Heterogeneity of circulating insulin and proinsulin in man.
Horwitz DL; Rubenstein AH
Isr J Med Sci; 1974 Oct; 10(10):1201-11. PubMed ID: 4373412
[No Abstract] [Full Text] [Related]
11. The use of artificial beta cell in diagnosis and treatment of insulinoma.
Raptis S; Zoupas C; Dimitriadis G; Moulopoulos S
Horm Metab Res Suppl; 1979; (8):169-72. PubMed ID: 231567
[TBL] [Abstract][Full Text] [Related]
12. Production of pro-insulin, C-peptide, and insulin in nesidioblastosis, focal islet-cell adenomatosis, and genuine insulomas. A correlated radioimmunochemical, immunohistochemical, and ultrastructural investigation with particular regard to the occurrence of argyrophil and pro-insulin immunoreactive cells.
Kohnert KD; Fält K; Odselius R; Ziegler M; Madsen OD; Grimelius L; Falkmer S
Diabetes Res; 1988 Aug; 8(4):151-63. PubMed ID: 2853026
[TBL] [Abstract][Full Text] [Related]
13. Proinsulin and C-peptide: a review.
Kitabchi AE
Metabolism; 1977 May; 26(5):547-87. PubMed ID: 403392
[TBL] [Abstract][Full Text] [Related]
14. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
[TBL] [Abstract][Full Text] [Related]
15. [The occurrence of proinsulin and C-peptide in healthy humans and in diabetics].
Beischer W
Fortschr Med; 1982 Sep; 100(33):1508-12. PubMed ID: 7129312
[TBL] [Abstract][Full Text] [Related]
16. [Current concepts concerning insulin resistance].
Rossi G
Recenti Prog Med; 1981 Sep; 71(3):264-73. PubMed ID: 7034082
[No Abstract] [Full Text] [Related]
17. [Proinsulin, C-peptide reactive protein (CPR)].
Takahashi R; Oka Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():488-92. PubMed ID: 16149558
[No Abstract] [Full Text] [Related]
18. Secretory function of pancreatic beta cell during insulin-induced hypoglycemia evaluated by C-peptide immunoreactivity (CPR) determination.
Shima K; Tanaka R; Morishita S; Sawazaki N; Ichihara K; Kumahara Y; Yanaihara N
Med J Osaka Univ; 1978 Dec; 29(3-4):221-8. PubMed ID: 379559
[No Abstract] [Full Text] [Related]
19. C-peptide, Na+,K(+)-ATPase, and diabetes.
Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
[TBL] [Abstract][Full Text] [Related]
20. [C-peptide measurement in the classification of diabetes mellitus and in the assessment of requirements for insulin treatment].
Gjessing HJ
Ugeskr Laeger; 1990 Feb; 152(9):588-93. PubMed ID: 2408222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
